-
Tirzepatide returns to the spotlight on the final day of the Scientific Sessions
After SURMOUNT-1 trial results were reported at the Scientific Sessions on Saturday and made worldwide headlines, a special session on Tuesday, June 7, will showcase more than 20 tirzepatide abstracts presented over the five days of the meeting. “Attendees are seeing and hearing data that is being presented for the first time here in New…
-
Researchers will report new findings on the mechanisms of diabetic kidney disease
Genomic analysis, single-cell sequencing, and epigenomic approaches are uncovering new mechanisms in the development and progression of diabetic kidney disease. A panel of researchers, including Jose C. Florez, MD, PhD, will provide an update on the latest discoveries.
-
Similarities—and differences—in the many forms of diabetes make it necessary to rethink the disease, speaker says
Richard David Leslie, MBBS, MRCS, MD, FRCP, FAoP, says diabetes should be rethought. He will open a unique symposium on the final day of the 82nd Scientific Sessions that will examine various aspects of heterogeneity in diabetes.
-
Researchers are gaining better understanding of increased risk of cognitive decline, dementia in type 2 diabetes
Three neurological researchers—Auriel Willette, PhD, Vera Novak, MD, PhD, and Valory Pavlik, PhD (left to right)—will discuss the links between diabetes and cognitive decline and explore possible interventions during a Scientific Sessions symposium on Tuesday, June, 7.
-
Overlooked no more, cilia are emerging as key players in insulin secretion
Once thought of as nonfunctional vestigial relics of evolutionary history, cilia are emerging as critical components in multiple signaling pathways that control sight, smell, renal function, feeding behavior and obesity, skeletal formation, and, most recently, insulin secretion and glucose homeostasis. “Cilia biology is going to explode in diabetes,” predicts Jing Hughes, MD, PhD.
-
Investigators are examining the impact of the circadian clock on metabolic health
Four researchers, including Dongyin Guan, PhD (left), Kristin Eckel-Mahan, PhD, will discuss how circadian misalignment impacts metabolic health during a Scientific Sessions symposium on Tuesday, June 7.
-
ADA President, Medicine & Science: Individualized glucose management needed in hospital settings
Guillermo E. Umpierrez, MD, CDCES, FACP, FACE, ADA President, Medicine & Science, discussed the need for individualized glucose management for non-ICU hospital patients with type 2 diabetes on Sunday, June 5, at the 82nd Scientific Sessions.
-
Banting Medal awardee makes the case for glucokinase as a novel target in type 2 diabetes
Frances M. Ashcroft, DBE, FRS, FMedSci, recipient of the ADA’s 2022 Banting Medal for Scientific Achievement, discussed a novel approach—inhibiting glucokinase activity to improve insulin secretion—for treating type 2 diabetes during her award lecture on Sunday, June 5.
-
Panelists review highlights in clinical, basic, and translational science from the past year
Linda DiMeglio, MD, MPH, David A. D’Alessio, MD, and Silvia Corvera, MD (left to right), reviewed some of the key advances in diabetes research and care during the annual Year in Review session.
-
Stigma is a significant, often overlooked obstacle in diabetes management
Five behavioral health specialists discussed the effects of stigma in diabetes care during an afternoon symposium on Saturday, June 4. Alan M. Delamater, PhD, opened the symposium by recounting his 40-year journey in behavioral diabetes research as he presented the annual Richard R. Rubin Award Lecture.